JPRN-UMIN000017711已完成未知
Efficacy of high dosage of betahistine in patients with unilateral peripheral vestibulopathy - Efficacy of high dosage of betahistine in patients with unilateral peripheral vestibulopathy
niversity of Tokushima0 个研究点目标入组 225 人开始时间: 2015年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with peptic ulcer. 2) Patients with bronchial asthma. 3) Patients with pheochromocytoma. 4) Pregnant and breast-feeding female patients 5) Patients who suffered from repetitive vertigo attacks 6) Patients who was excluded by investigators.
研究者
相似试验
招募中
不适用
Effect of betahistine in treating in patients with peripheral vestibular diseaseperipheral vestibular diseaseJPRN-UMIN000032573niversity of Toyama15
进行中（未招募）
不适用
The effect of betahistine 48 mg three times daily on motion sickness - betahistineEUCTR2008-000885-21-NLTNO
尚未招募
2 期
The effect of betahistine 48 mg three times daily on motion sicknessbewegingsziektemotion disturbance10027667motion sicknessNL-OMON32365TNO26
已完成
1 期
Pharmacokinetic profile of betahistine blood concentration with and without selegiline in healthy volunteers - a mono-center, open-labeled phase I trialhealthy volunteersDRKS00023352MU Klinikum Neurologische Klinik und Poliklinik15
已完成
3 期
Aripiprazle in ADHD and ODDAttention deficit/hyperactivity disorder.Attention deficit/hyperactivity disorderIRCT20160530028182N6Sanandaj University of Medical Sciences76